StemiRNA Therapeutics Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 32

StemiRNA Therapeutics General Information

Description

Developer of mRNA technology-based physical products designed for the medical field. The company's technology utilizes a proprietary LPP nanotechnology-based delivery platform, AI-driven drug design, and mRNA synthesis capabilities, enabling healthcare providers to access stable vaccines and personalized oncology immunotherapies for infectious diseases and cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 402, Building 2
  • Number 1295 Chuanqiao Road, Pudong New Area
  • Shanghai, 200100
  • China
+86 021
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Room 402, Building 2
  • Number 1295 Chuanqiao Road, Pudong New Area
  • Shanghai, 200100
  • China
+86 021

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

StemiRNA Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC 25-May-2023 Completed Generating Revenue
9. Later Stage VC 26-Sep-2021 Completed Generating Revenue
8. Later Stage VC 28-May-2021 Completed Generating Revenue
7. Secondary Transaction - Private 30-Mar-2021 Completed Generating Revenue
6. Early Stage VC (Series A1) 21-Feb-2020 Completed Generating Revenue
5. Early Stage VC (Series A) 01-Jul-2019 Completed Generating Revenue
4. Secondary Transaction - Private 06-Jun-2018 Completed Generating Revenue
3. Early Stage VC 06-Jun-2018 Completed Generating Revenue
2. Early Stage VC 01-Sep-2017 $3M $3M Completed Generating Revenue
1. Secondary Transaction - Private 09-Apr-2017 Completed Generating Revenue
To view StemiRNA Therapeutics’s complete valuation and funding history, request access »

StemiRNA Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of mRNA technology-based physical products designed for the medical field. The company's technology utilizes a
Drug Discovery
Shanghai, China

Mainz, Germany
 

San Diego, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

StemiRNA Therapeutics Competitors (3)

One of StemiRNA Therapeutics’s 3 competitors is BioNTech, a Formerly VC-backed company based in Mainz, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioNTech Formerly VC-backed Mainz, Germany
Arcturus Therapeutics Holdings Formerly VC-backed San Diego, CA
Moderna Formerly VC-backed Cambridge, MA
You’re viewing 3 of 3 competitors. Get the full list »

StemiRNA Therapeutics Patents

StemiRNA Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2024131726-A1 Broad-spectrum influenza mrna vaccine Inactive 19-Dec-2022
WO-2024098360-A1 Artificial nucleic acid molecule Inactive 11-Nov-2022
WO-2024098361-A1 Artificial nucleic acid molecule Inactive 11-Nov-2022
WO-2024094211-A1 Lipid composition Inactive 06-Nov-2022
WO-2024032611-A1 Lipid composition Inactive 09-Aug-2022 A61K9/1272
To view StemiRNA Therapeutics’s complete patent history, request access »

StemiRNA Therapeutics Investors (32)

Investor Name Investor Type Holding Investor Since Participating Rounds
Spinnotec Venture Capital Minority
Oceanpine Capital Growth/Expansion Minority
Qianhai Great Wall Fund Management (Shenzhen) Growth/Expansion Minority
Silver Capital (China) Venture Capital Minority
Advantech Capital Partners PE/Buyout Minority
You’re viewing 5 of 32 investors. Get the full list »

StemiRNA Therapeutics FAQs

  • When was StemiRNA Therapeutics founded?

    StemiRNA Therapeutics was founded in 2016.

  • Where is StemiRNA Therapeutics headquartered?

    StemiRNA Therapeutics is headquartered in Shanghai, China.

  • What industry is StemiRNA Therapeutics in?

    StemiRNA Therapeutics’s primary industry is Drug Discovery.

  • Is StemiRNA Therapeutics a private or public company?

    StemiRNA Therapeutics is a Private company.

  • What is StemiRNA Therapeutics’s current revenue?

    The current revenue for StemiRNA Therapeutics is .

  • How much funding has StemiRNA Therapeutics raised over time?

    StemiRNA Therapeutics has raised $208M.

  • Who are StemiRNA Therapeutics’s investors?

    Spinnotec, Oceanpine Capital, Qianhai Great Wall Fund Management (Shenzhen), Silver Capital (China), and Advantech Capital Partners are 5 of 32 investors who have invested in StemiRNA Therapeutics.

  • Who are StemiRNA Therapeutics’s competitors?

    BioNTech, Arcturus Therapeutics Holdings, and Moderna are competitors of StemiRNA Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process